This story has been updated to include additional information from Oxford Nanopore and Novo Holdings.

这个故事已经更新，包括牛津纳米孔公司和诺沃控股公司的其他信息。

NEW YORK – Oxford Nanopore Technologies said Thursday that the company has raised approximately £80 million ($102.5 million) through a placement of new ordinary shares, including a strategic investment of approximately £50 million from life sciences investor Novo Holdings.

纽约-牛津纳米孔技术公司（Oxford Nanopore Technologies）周四表示，该公司通过发行新的普通股筹集了约8000万英镑（1.025亿美元），其中包括生命科学投资者Novo Holdings的约5000万英镑战略投资。

The equity raise exceeded the company's original goal, announced on Wednesday, of raising a total of £75 million.

此次股权融资超过了该公司周三宣布的原始目标，即融资总额为7500万英镑。

The UK nanopore sequencing firm said it will issue 25,000,000 new ordinary shares of £.0001 each at an issue price of 120 pence per share with institutional investors, raising gross proceeds of approximately £30 million. The total number of new ordinary shares will be approximately 8 percent of the existing issued share capital of the company..

这家英国纳米孔测序公司表示，将与机构投资者以每股120便士的发行价格发行250万股新普通股，每股0.0001英镑，总收益约为3000万英镑。新普通股总数约为公司现有已发行股本的8%。。

In addition, Novo Holdings has committed to subscribe for 41,666,667 of Oxford Nanopore’s new ordinary shares at the placing price, resulting in gross proceeds of approximately £50 million for the company. Novo Holdings said it intends to make further share purchases of up to £10 million over time in the secondary market, subject to availability and price..

此外，Novo Holdings已承诺以配售价格认购牛津纳米孔公司41666667股新普通股，为公司带来约5000万英镑的总收益。Novo Holdings表示，它打算根据可用性和价格，在二级市场上进一步购买高达1000万英镑的股票。。

Oxford Nanopore said the money raised will be used for general corporate purposes. 'This investment reinforces and validates Oxford Nanopore's strategy and future growth plans across each of its end markets,' the company said in a statement.

牛津纳米孔表示，筹集的资金将用于一般企业用途该公司在一份声明中说，这项投资加强并验证了牛津纳米孔公司在各个终端市场的战略和未来增长计划。

Citigroup Global Markets, JP Morgan Securities, and Joh. Berenberg, Gossler & Co. were the joint global coordinators, bookrunners, and corporate brokers for the placement.

花旗集团全球市场部、摩根大通证券和约翰。Berenberg、Gossler&Co.是此次配售的联合全球协调员、账簿管理人和公司经纪人。

'We are confident in Oxford Nanopore's long-term value proposition after extensive due diligence within the biopharma community and analysis of their robust and extensive IP portfolio, and we look forward to supporting the company going forward,' Daniel Mahony, Novo Holdings' senior partner of growth investments, said in a statement. .

Novo Holdings的growth investments高级合伙人丹尼尔·马奥尼（DanielMahony）在一份声明中说，在生物制药界进行了广泛的尽职调查，并对其强大而广泛的知识产权投资组合进行了分析之后，我们对牛津纳米孔的长期价值主张充满信心，我们期待着为公司的发展提供支持。。